CNS Drugs provides researchers and healthcare professionals involved in the care of individuals with neurological and psychiatric disorders with essential information on the most important aspects of drug therapy.
Via a program of review articles, the journal addresses the major issues relating to the drug therapy of these disorders. These include the pharmacology, efficacy and adverse effects of the major classes of drugs used by neurologists and psychiatrists; information on newly developed drugs and drug classes; the therapeutic implications of the latest research into the aetiology of neurological and psychiatric disorders; and the practical management of specific disorders. CNS Drugs also offers a vehicle for the publication of important clinical research papers to assist in the dissemination of information on which clinicians can base their prescribing.
- 29 Volumes
- 272 Issues
- 1,845 Articles
- 28 Open Access
- 1994 - 2015 Available between
Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
Agnieszka Nikiforuk (February 2015)
- Journal Title
- CNS Drugs
- Volume 1 / 1994 - Volume 29 / 2015
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.